These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15146788)

  • 1. [Advances in pharmacologic treatment of gastroesophageal reflux disease].
    Nogueira de Rojas JR
    Rev Gastroenterol Mex; 2003 Nov; 68 Suppl 3():22-8. PubMed ID: 15146788
    [No Abstract]   [Full Text] [Related]  

  • 2. Acid inhibition and gastroesophageal reflux disease.
    Sachs G
    Yale J Biol Med; 1999; 72(2-3):227-9. PubMed ID: 10780585
    [No Abstract]   [Full Text] [Related]  

  • 3. Tough-to-treat gastro-oesophageal reflux disease patients: who are they and how to treat?
    Howden C
    Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():11-4, 21-4. PubMed ID: 15755269
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug interactions between proton pump inhibitors and antiretroviral drugs.
    McCabe SM; Smith PF; Ma Q; Morse GD
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):197-207. PubMed ID: 17428151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in proton pump inhibitors and management of acid-peptic disorders.
    Jain KS; Shah AK; Bariwal J; Shelke SM; Kale AP; Jagtap JR; Bhosale AV
    Bioorg Med Chem; 2007 Feb; 15(3):1181-205. PubMed ID: 17150362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
    Jensen RT
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
    Omari TI; Haslam RR; Lundborg P; Davidson GP
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):41-4. PubMed ID: 17204951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori infection and antisecretory efficacy of proton-pump inhibitors in gastroesophageal reflux disease: a liaison dangereuse or an innocent interplay?
    Parente FR; Bargiggia SA; Anderloni A
    Scand J Gastroenterol; 2006 Oct; 41(10):1121-5. PubMed ID: 16990195
    [No Abstract]   [Full Text] [Related]  

  • 9. [Night acid "bursting": treatment of patients with gastroesophageal reflux disease].
    Vasil'ev IuV; Beliaeva VS
    Eksp Klin Gastroenterol; 2007; (3):83-91. PubMed ID: 17937011
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug treatment of gastroesophageal reflux disease].
    Malfertheiner P
    Dtsch Med Wochenschr; 2003 Feb; 128(8):396-7. PubMed ID: 12594627
    [No Abstract]   [Full Text] [Related]  

  • 11. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
    Delaney B; McColl K
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():32-40. PubMed ID: 16042657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor failure: why does it occur and how can it be managed?
    Savarino V; Savarino E; Dulbecco P
    Digestion; 2006; 73(4):215-7. PubMed ID: 16883072
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gastroesophageal reflux disease: medical or surgical treatment?].
    Hölscher AH; Bollschweiler E; Rösch W
    Dtsch Med Wochenschr; 2004 Apr; 129(17):967-9. PubMed ID: 15083401
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of reflux disease with proton pump inhibitors].
    Rösch W
    Pharm Unserer Zeit; 2005; 34(3):210-5. PubMed ID: 15940954
    [No Abstract]   [Full Text] [Related]  

  • 15. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New diagnostic procedures in gastroesophageal reflux disease: from the Bernstein test to impedance].
    Valdovinos Díaz MA; Gómez Escudero O
    Rev Gastroenterol Mex; 2003 Nov; 68 Suppl 3():4-11. PubMed ID: 15146784
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction: the scientific and clinical rationale for extended acid suppression.
    Katz PO
    Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():1. PubMed ID: 16700897
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation between gastric pH and gastro-oesophageal reflux contents: ambulatory pH-impedance monitoring results.
    Roman S; Serraj I; Damon H; Mion F
    Neurogastroenterol Motil; 2007 Jul; 19(7):562-8. PubMed ID: 17593137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.